Use of a prenylation inhibitor as a novel antiviral agent.
about
By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expressionAmphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA ReplicationManagement of hepatitis delta: Need for novel therapeutic optionsHepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acidsLong-term therapy of chronic delta hepatitis with peginterferon alfa.Murine guanylate-binding protein: incomplete geranylgeranyl isoprenoid modification of an interferon-gamma-inducible guanosine triphosphate-binding proteinDisruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.Unique properties of the large antigen of hepatitis delta virus.A prenylation inhibitor prevents production of infectious hepatitis delta virus particlesIn vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication.A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication.Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.
P2860
Q24564116-624E2A90-252C-467B-AC14-D2A559352783Q27473477-20A1D34C-FE95-465D-9861-F5E7FDD6EDD7Q28082312-77C5AFA0-7BDA-4B77-9BD1-E0E302280E93Q29620653-AB42B9B1-DC4D-4154-BF92-98AAF4520A5FQ33904679-E40F962D-A5E9-487A-92C3-C08BCA0D56E5Q34728624-46F54D53-FB1C-4EAF-A755-228151C00593Q34792600-4E5BCCF5-F8C2-4108-8846-B3C4215C7DB7Q36428213-8B93444D-6ED6-45A6-8E42-DA5695FB31DFQ38296605-89C74C03-7D8D-43DF-B536-49A05F1ABD29Q39550784-813A3BBF-853D-47CD-B321-2BF8AB165D6CQ39684955-BCB20485-4799-4D2B-899A-84E8A7B23C2AQ39793276-89AD6A99-5C41-4AEC-AB96-C46EF8FD7A9DQ40162016-20ADA7B9-79DC-46A6-A8F7-0EC6F8133378Q40162438-2FE66DB0-D8F5-4254-A205-0170BF8C7774Q47239374-52D75C85-FAA8-4A79-96D1-18373A24708F
P2860
Use of a prenylation inhibitor as a novel antiviral agent.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Use of a prenylation inhibitor as a novel antiviral agent.
@en
Use of a prenylation inhibitor as a novel antiviral agent.
@nl
type
label
Use of a prenylation inhibitor as a novel antiviral agent.
@en
Use of a prenylation inhibitor as a novel antiviral agent.
@nl
prefLabel
Use of a prenylation inhibitor as a novel antiviral agent.
@en
Use of a prenylation inhibitor as a novel antiviral agent.
@nl
P2093
P2860
P1433
P1476
Use of a prenylation inhibitor as a novel antiviral agent
@en
P2093
H B Greenberg
J C Marsters
P2860
P304
P407
P577
1998-11-01T00:00:00Z